NUMANS Sets 30 April 2026 Board Meeting to Approve FY 2025 Results; Trading Remains Suspended

Bulletin Express
04/20

Numans Health Food Holdings Company Limited (NUMANS) has scheduled a board meeting for 30 April 2026 to review and approve its consolidated financial results for the year ended 31 December 2025, as well as to consider a possible final dividend.

Trading in NUMANS shares has been suspended since 9:00 a.m. on 1 April 2026 and will remain halted until the FY 2025 results are released. The suspension follows the company’s 31 March 2026 disclosure regarding the delay in publishing its annual results.

The current board comprises Chairman Wang Ping and Executive Director Cui Juan, Non-Executive Director Chan Hok Leung, and Independent Non-Executive Directors Yim Wing Yee, Lau Kwok Fai Patrick, and Yu Tsz Ngo.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10